David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Corteva
CTVA
$55.3B
| $370K | ﹤0.01% |
+4,971
| New | +$331K |
|
|
SLI
3652
Standard Lithium
SLI
$600M
| $370K | ﹤0.01% |
188,916
+24,060
| +15% | +$37.9K |
|
3653
CALL
Caleres
CAL
$459M
| $370K | ﹤0.01% |
30,300
+10,000
| +49% | +$150K |
|
3654
Mercantile Bank Corp
MBWM
$1.04B
| $369K | ﹤0.01% |
7,944
-1,147
| -13% | -$49.7K |
|
3655
PUT
Coca-Cola
KO
$396B
| $368K | ﹤0.01% |
5,200
-135,800
| -96% | -$9.67M |
|
3656
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.44B
| $367K | ﹤0.01% |
9,766
-4,093
| -30% | -$147K |
|
3657
KB Home
KBH
$3.41B
| $366K | ﹤0.01% |
6,917
-1,680
| -20% | -$89.3K |
|
3658
NovoCure
NVCR
$1.95B
| $366K | ﹤0.01% |
+20,556
| New | +$358K |
|
3659
CALL
Huntsman Corp
HUN
$1.68B
| $365K | ﹤0.01% |
+35,000
| New | +$426K |
|
3660
Tecnoglass Holdings
TGLS
$1.8B
| $364K | ﹤0.01% |
+4,700
| New | +$365K |
|
3661
PUT
J.M. Smucker
SJM
$13.5B
| $363K | ﹤0.01% |
+3,700
| New | +$407K |
|
|
GES
3662
PUT
DELISTED
Guess Inc
GES
| $363K | ﹤0.01% |
30,000
-35,000
| -54% | -$391K |
|
3663
PUT
Ally Financial
ALLY
$12.9B
| $362K | ﹤0.01% |
9,300
-77,200
| -89% | -$2.67M |
|
3664
South Plains Financial
SPFI
$829M
| $361K | ﹤0.01% |
10,024
-2,614
| -21% | -$89.9K |
|
3665
Healthcare Realty
HR
$6.62B
| $361K | ﹤0.01% |
22,760
-29,014
| -56% | -$441K |
|
|
API
3666
Agora
API
$358M
| $360K | ﹤0.01% |
94,386
| – | – |
|
3667
EPAM Systems
EPAM
$5.74B
| $357K | ﹤0.01% |
2,020
-72,861
| -97% | -$12.2M |
|
3668
Vera Therapeutics
VERA
$2.43B
| $357K | ﹤0.01% |
+15,154
| New | +$341K |
|
3669
Safe Bulkers
SB
$881M
| $356K | ﹤0.01% |
98,659
-92,226
| -48% | -$330K |
|
3670
CALL
indie Semiconductor
INDI
$828M
| $356K | ﹤0.01% |
100,000
| – | – |
|
3671
Highwoods Properties
HIW
$3.5B
| $356K | ﹤0.01% |
11,437
-23,202
| -67% | -$683K |
|
3672
CALL
Virgin Galactic
SPCE
$455M
| $355K | ﹤0.01% |
130,000
| – | – |
|
3673
State Street SPDR Dow Jones REIT ETF
RWR
$1.88B
| $355K | ﹤0.01% |
3,679
-3,107
| -46% | -$298K |
|
3674
US Foods
USFD
$23.7B
| $355K | ﹤0.01% |
4,606
-8,994
| -66% | -$642K |
|
3675
Core Laboratories
CLB
$553M
| $354K | ﹤0.01% |
30,738
-17,614
| -36% | -$209K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.